Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and Omega-3 Detection in Schirmer's Test Strips
NCT05775536Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2021
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of aspirin and omega-3 fatty acid in dry eye syndrome (DED), sponsored by Medical University of Vienna. Primary endpoint: Concentration of omega-3 fatty acids/ASA detectable in Schirmer's tear strips at 1 week. Started Jan 2021; status: completed.
02
Drugs
aspirinomega-3 fatty acid
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT05775536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05775536.